| HTXS: Treatment: Adult Treatment |
$606,923,348 |
| HTXD: Treatment: ARV Drugs |
$335,971,532 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission |
$323,206,405 |
| OHSS: Health Systems Strengthening |
$295,286,434 |
| HKID: Care: Orphans and Vulnerable Children |
$275,060,642 |
| HBHC: Care: Adult Care and Support |
$252,638,741 |
| HVOP: Sexual Prevention: Other Sexual Prevention |
$215,327,314 |
| HVMS: Management and Operations |
$209,579,252 |
| HLAB: Laboratory Infrastructure |
$191,740,468 |
| HVCT: Testing: HIV Testing and Counseling |
$191,209,818 |
| HVSI: Strategic Information |
$179,601,068 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision |
$168,670,637 |
| HVTB: Care: TB/HIV |
$138,282,977 |
| PDTX: Treatment: Pediatric Treatment |
$108,040,114 |
| PDCS: Care: Pediatric Care and Support |
$52,264,248 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful |
$47,094,437 |
| HMBL: Biomedical Prevention: Blood Safety |
$37,980,070 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use |
$25,058,095 |
| HMIN: Biomedical Prevention: Injection Safety |
$13,601,584 |
